2020
DOI: 10.1016/j.braindev.2019.12.004
|View full text |Cite
|
Sign up to set email alerts
|

Acute encephalopathy with biphasic seizures and late reduced diffusion in a Spanish girl

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…It seems that HHV-7 infection is linked to severe and uncommon neurologic entities. 14,15 In our case, at the end of treatment with ganciclovir-a nucleoside analog-, the CSF PCR was negative for HHV-7. There are limited pharmaceutical agents for the treatment of severe HHV-7 infection.…”
Section: Case Reportmentioning
confidence: 57%
See 1 more Smart Citation
“…It seems that HHV-7 infection is linked to severe and uncommon neurologic entities. 14,15 In our case, at the end of treatment with ganciclovir-a nucleoside analog-, the CSF PCR was negative for HHV-7. There are limited pharmaceutical agents for the treatment of severe HHV-7 infection.…”
Section: Case Reportmentioning
confidence: 57%
“…AESD is a new encephalopathy syndrome, characterized by biphasic seizures and reduced diffusion on MRI the first week of illness. It seems that HHV‐7 infection is linked to severe and uncommon neurologic entities 14,15 …”
Section: Discussionmentioning
confidence: 99%
“…AESD has been almost exclusively reported in the Japanese literature, comprising 34% of the acute encephalopathies seen and most commonly associated with HHV‐8 and influenza A viruses 2 . However, AESD has also been described in Europe, Australia, and North America 3–6 . Patients are usually previously well and present with altered level of consciousness and variable focal neurological signs usually coming from symmetrical lesions in the frontal‐temporal region; 34% recover completely, while 61% experience mild to moderate persistent deficits 1,2 .…”
Section: Introductionmentioning
confidence: 99%
“…2 However, AESD has also been described in Europe, Australia, and North America. [3][4][5][6] Patients are usually previously well and present with altered level of consciousness and variable focal neurological signs usually coming from symmetrical lesions in the frontal-temporal region; 34% recover completely, while 61% experience mild to moderate persistent deficits. 1,2 The condition is fatal in less than 2% of cases.…”
mentioning
confidence: 99%